CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 4 enrolled
Drug / intervention
Apsara Thermal Wand Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00662389
NCT00662389Early Ph 1Completed
CompareCT.gov

TP-1013 Pilot 1: Application of the Apsara Thermal Wand System

Apsara Medical Corporation·interventional·Posted Apr 21, 2008·Updated Aug 28, 2009

In Brief

A Early Phase 1 clinical trial evaluating Apsara Thermal Wand System for Tightening of Skin Laxity. Completed, enrolled 4 participants across 1 site.

Detailed Summary

The purpose of this feasibility study is to gain an initial assessment of the acute safety and performance of the Apsara Thermal Wand System in human facial tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTightening of Skin Laxity
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 21, 2008
Enrollment StartApr 1, 2008
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.2 years ago

Interventions

Apsara Thermal Wand Systemdevice

Single radiofrequency cycle to dermal tissue